Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.

NCT01927406 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT01927406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01927406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Secondary Beneficial Effects of Prostaglandin Analog Treatment in Thyroid Eye Disease Patients.
Lead sponsor
Stanford University
Phase
Phase 4
Overall status
Withdrawn
Start date
June 30, 2014
Completion date
December 31, 2016
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, ocular hypertension, thyroid eye disease